Developer docs
API playgroundTry for free, no card

Search company profiles

Axana

Full company profile

uuid006hd93

Namestring
Axana
Legal namestring
Axana B.V.
Websiteurl
axana.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Axana B.V. is a Netherlands-incorporated, UK-operating clinical software company that builds Axana MDT, an AI-powered platform supporting multidisciplinary team (MDT) processes for cancer care in hospitals. The platform addresses workflow fragmentation in oncology by aggregating patient and case data for MDT meetings, automating documentation and decision recording, verifying case readiness to reduce deferrals, issuing automated patient follow-up reminders, and monitoring patient progress against clinical pathways with proactive delay identification. The product is deployed either on-premise within hospital secure networks or via public cloud with encrypted connections, hosted in NHS England-approved data centres for UK NHS customers, and is governed under a dual Data Controller/Data Processor legal framework compliant with UK GDPR, the Data Protection Act 2018, and ICO registration.

The company is built by the team behind Aidence, which previously deployed AI solutions in over 100 UK and EU hospitals, and leverages that institutional track record as its primary credibility signal. Axana operates a subscription-based clinical software licensing model, selling directly to NHS hospital trusts through an enterprise sales motion initiated via website 'Book a demo' and 'Get in contact' CTAs; pricing is not publicly disclosed. The customer base is concentrated in UK NHS hospital trusts, with the anonymised aggregated statistical reporting capability positioned both as a benchmark for product improvement and as a potential future commercial asset. The company has no disclosed funding rounds, management team, headcount, or revenue, indicating an early-stage commercial profile.

Short descriptiontext

Axana B.V. builds Axana MDT, an AI-powered clinical software platform that supports multidisciplinary team workflows for cancer care in UK NHS hospitals. The platform automates case preparation, documentation, pathway monitoring, and patient follow-up tracking for oncology teams.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAmsterdam, Netherlands
HQ citystring
Amsterdam
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer care software, multidisciplinary team platform, oncology workflow automation, clinical decision support, healthcare AI platform
Industry1 code
PRIMARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code1 code
  • Computer Systems Design Services541512
SIC code1 code
  • Services-Health Services8000
Product category
Clinical Decision Support Software
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Software Licensing (Axana MDT)
TypeSubscription Recurring
Description

Software licensing model for Axana MDT deployed in NHS and EU hospitals. The company acts as Data Processor when processing patient data for direct clinical care and provides IT support and regular software updates. Revenue is generated through software deployment in healthcare institutions.

axana.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Axana MDT
Description

Clinical software product used by healthcare professionals and administrators to support multidisciplinary team (MDT) processes in UK hospitals.

axana.com
Core offering1 text field

Axana develops and sells Axana MDT, an AI-powered clinical software platform used by NHS and EU hospitals to support multidisciplinary team (MDT) processes in cancer care. The platform automates case preparation, data aggregation, documentation, decision recording, pathway management, and patient follow-up tracking, deployed on-premise or via secure cloud in NHS England-approved data centres.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • AI-powered data aggregation reduces manual data collection time for MDT preparation
+2 more records
Product overview1 text field

Axana is a unified AI-powered cancer care platform consisting of a single core product called Axana MDT. The platform provides workflow tools for cancer care including data collection, MDT preparation and optimisation, tasks and worklists, pathway management, and online collaboration. The product is designed for healthcare professionals and administrators in UK hospitals to streamline multidisciplinary team processes, reduce administrative burden, and improve patient outcomes.

Product and service1 record
1Axana MDT
CategoryClinical Decision Support Software - Oncology MDT
Description

Clinical software platform used by healthcare professionals and administrators in NHS and EU hospitals to support multidisciplinary team (MDT) processes for cancer care. It provides AI-powered data aggregation, case preparation, automated documentation and decision recording, pathway management, follow-up tracking, and anonymised statistical reporting, deployed on-premise within hospital secure networks or via secure cloud hosted in NHS England-approved data centres.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

DrDoctor is a UK-based patient engagement and clinical workflow platform serving NHS trusts with digital communication, appointment management, and pathway tools. It is comparable as an NHS-focused clinical workflow SaaS vendor with similar go-to-market motion and customer base (UK hospital trusts).

TypeBroad incumbent
Description

Brainlab is a Germany-based broader incumbent in digital surgery, oncology software, and clinical workflow platforms used in hospitals globally. It is comparable as a vendor of oncology-focused clinical software with hospital deployments, operating in adjacent workflow areas such as tumor boards and multidisciplinary oncology planning.

TypeDirect peer
Description

Aidence is the predecessor company founded by the same team as Axana, focused on AI-powered radiology solutions deployed in 100+ UK & EU hospitals. It is the most directly comparable peer as it shares the founding team, geographic focus, NHS customer base, and AI-for-clinical-workflows positioning—Axana explicitly markets itself as being 'from the makers of Aidence.'

4Babylon Health
TypeBroad incumbent
Description

Babylon Health was a UK-based AI healthcare platform providing digital triage, consultations, and care navigation to NHS patients. Though it has undergone significant restructuring, it is comparable as a pioneering UK AI-health vendor operating within the NHS ecosystem and addressing clinical workflow automation.

TypeDirect peer
Description

Concentric Health is a UK digital health company providing clinical workflow and consent platforms deployed across NHS trusts. It is comparable as a B2B digital health vendor selling workflow software directly to NHS hospitals, operating under similar regulatory and procurement constraints as Axana.

TypeDirect peer
Description

Optellum is an AI-driven clinical decision support platform for lung cancer diagnosis and management, with NHS and US deployments. It is comparable as a cancer-focused AI platform serving pulmonology and oncology workflows, with similar product-led growth motion and clinical-evidence-led positioning in regulated health systems.

TypeDirect peer
Description

C the Signs is a UK-based AI clinical decision support tool that helps GPs identify patients at risk of cancer at the earliest stage. It is comparable as a UK cancer-focused AI platform operating in the NHS, targeting clinical pathway optimisation and early diagnosis workflows.

TypeBroad incumbent
Description

Huma is a UK-based digital health platform providing remote patient monitoring, digital biomarkers, and care coordination tools across multiple therapeutic areas. It is a broader incumbent with larger funding and a wider portfolio, but overlaps with Axana in NHS deployments and clinical care coordination workflows.

TypeDirect peer
Description

Kheiron Medical is a UK-based AI company applying deep learning to radiology and cancer diagnostics, particularly breast cancer screening. It is comparable as a UK-headquartered clinical AI vendor with NHS deployments, targeting cancer care workflows, and operating under similar regulatory and data-compliance constraints as Axana.

TypeBroad incumbent
Description

Epic Systems is the dominant US-based EHR vendor increasingly penetrating the NHS market (e.g., Manchester University NHS Foundation Trust) and offering oncology modules that include MDT coordination features. It is a broad incumbent that represents the primary competitive threat to Axana as integrated EHR platforms absorb specialised workflow tools.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Axana

Clinical Decision Support Softwareaxana.com

Axana B.V. builds Axana MDT, an AI-powered clinical software platform that supports multidisciplinary team workflows for cancer care in UK NHS hospitals. The platform automates case preparation, documentation, pathway monitoring, and patient follow-up tracking for oncology teams.

What Axana does

Axana B.V. is a Netherlands-incorporated, UK-operating clinical software company that builds Axana MDT, an AI-powered platform supporting multidisciplinary team (MDT) processes for cancer care in hospitals. The platform addresses workflow fragmentation in oncology by aggregating patient and case data for MDT meetings, automating documentation and decision recording, verifying case readiness to reduce deferrals, issuing automated patient follow-up reminders, and monitoring patient progress against clinical pathways with proactive delay identification. The product is deployed either on-premise within hospital secure networks or via public cloud with encrypted connections, hosted in NHS England-approved data centres for UK NHS customers, and is governed under a dual Data Controller/Data Processor legal framework compliant with UK GDPR, the Data Protection Act 2018, and ICO registration.

The company is built by the team behind Aidence, which previously deployed AI solutions in over 100 UK and EU hospitals, and leverages that institutional track record as its primary credibility signal. Axana operates a subscription-based clinical software licensing model, selling directly to NHS hospital trusts through an enterprise sales motion initiated via website 'Book a demo' and 'Get in contact' CTAs; pricing is not publicly disclosed. The customer base is concentrated in UK NHS hospital trusts, with the anonymised aggregated statistical reporting capability positioned both as a benchmark for product improvement and as a potential future commercial asset. The company has no disclosed funding rounds, management team, headcount, or revenue, indicating an early-stage commercial profile.

Axana firmographics

Firmographics
Name
Axana
Legal name
Axana B.V.
Website
https://axana.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
Axana B.V. builds Axana MDT, an AI-powered clinical software platform that supports multidisciplinary team workflows for cancer care in UK NHS hospitals. The platform automates case preparation, documentation, pathway monitoring, and patient follow-up tracking for oncology teams.
Ownership category
akta.pro rank

Axana industry classification

Industry
Product category
Clinical Decision Support Software
NAICS
Computer Systems Design Services (541512)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Cancer care software
  • Multidisciplinary team platform
  • Oncology workflow automation
  • Clinical decision support
  • Healthcare AI platform

Where Axana is headquartered

Location

Headquarters

HQ city
Amsterdam
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

Axana business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Clinical Software Licensing (Axana MDT): Software licensing model for Axana MDT deployed in NHS and EU hospitals. The company acts as Data Processor when processing patient data for direct clinical care and provides IT support and regular software updates. Revenue is generated through software deployment in healthcare institutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Axana product offering

Product offering

Core offering

Axana develops and sells Axana MDT, an AI-powered clinical software platform used by NHS and EU hospitals to support multidisciplinary team (MDT) processes in cancer care. The platform automates case preparation, data aggregation, documentation, decision recording, pathway management, and patient follow-up tracking, deployed on-premise or via secure cloud in NHS England-approved data centres.

Product overview

Axana is a unified AI-powered cancer care platform consisting of a single core product called Axana MDT. The platform provides workflow tools for cancer care including data collection, MDT preparation and optimisation, tasks and worklists, pathway management, and online collaboration. The product is designed for healthcare professionals and administrators in UK hospitals to streamline multidisciplinary team processes, reduce administrative burden, and improve patient outcomes.

Differentiator

Problem solved

Functional benefit

Brands

  • Axana MDT: Clinical software product used by healthcare professionals and administrators to support multidisciplinary team (MDT) processes in UK hospitals.

Products and services

  • Axana MDT Clinical software platform used by healthcare professionals and administrators in NHS and EU hospitals to support multidisciplinary team (MDT) processes for cancer care. It provides AI-powered data aggregation, case preparation, automated documentation and decision recording, pathway management, follow-up tracking, and anonymised statistical reporting, deployed on-premise within hospital secure networks or via secure cloud hosted in NHS England-approved data centres.

Quantifiable outcome

  • AI-powered data aggregation reduces manual data collection time for MDT preparation
  • +2 more outcomes

Companies that use Axana

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Axana technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Axana partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Axana competitors and assessment

Company assessment

Direct peers

  • DrDoctor: DrDoctor is a UK-based patient engagement and clinical workflow platform serving NHS trusts with digital communication, appointment management, and pathway tools. It is comparable as an NHS-focused clinical workflow SaaS vendor with similar go-to-market motion and customer base (UK hospital trusts).
  • Aidence: Aidence is the predecessor company founded by the same team as Axana, focused on AI-powered radiology solutions deployed in 100+ UK & EU hospitals. It is the most directly comparable peer as it shares the founding team, geographic focus, NHS customer base, and AI-for-clinical-workflows positioning—Axana explicitly markets itself as being 'from the makers of Aidence.'
  • Concentric Health: Concentric Health is a UK digital health company providing clinical workflow and consent platforms deployed across NHS trusts. It is comparable as a B2B digital health vendor selling workflow software directly to NHS hospitals, operating under similar regulatory and procurement constraints as Axana.
  • Optellum: Optellum is an AI-driven clinical decision support platform for lung cancer diagnosis and management, with NHS and US deployments. It is comparable as a cancer-focused AI platform serving pulmonology and oncology workflows, with similar product-led growth motion and clinical-evidence-led positioning in regulated health systems.
  • C the Signs: C the Signs is a UK-based AI clinical decision support tool that helps GPs identify patients at risk of cancer at the earliest stage. It is comparable as a UK cancer-focused AI platform operating in the NHS, targeting clinical pathway optimisation and early diagnosis workflows.
  • Kheiron Medical Technologies: Kheiron Medical is a UK-based AI company applying deep learning to radiology and cancer diagnostics, particularly breast cancer screening. It is comparable as a UK-headquartered clinical AI vendor with NHS deployments, targeting cancer care workflows, and operating under similar regulatory and data-compliance constraints as Axana.

Broad incumbents

  • Brainlab: Brainlab is a Germany-based broader incumbent in digital surgery, oncology software, and clinical workflow platforms used in hospitals globally. It is comparable as a vendor of oncology-focused clinical software with hospital deployments, operating in adjacent workflow areas such as tumor boards and multidisciplinary oncology planning.
  • Babylon Health: Babylon Health was a UK-based AI healthcare platform providing digital triage, consultations, and care navigation to NHS patients. Though it has undergone significant restructuring, it is comparable as a pioneering UK AI-health vendor operating within the NHS ecosystem and addressing clinical workflow automation.
  • Huma (formerly Medopad): Huma is a UK-based digital health platform providing remote patient monitoring, digital biomarkers, and care coordination tools across multiple therapeutic areas. It is a broader incumbent with larger funding and a wider portfolio, but overlaps with Axana in NHS deployments and clinical care coordination workflows.
  • Epic Systems: Epic Systems is the dominant US-based EHR vendor increasingly penetrating the NHS market (e.g., Manchester University NHS Foundation Trust) and offering oncology modules that include MDT coordination features. It is a broad incumbent that represents the primary competitive threat to Axana as integrated EHR platforms absorb specialised workflow tools.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Axana financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Axana leadership team

Management profile

Number of profiles

Axana funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Axana M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Axana

What does Axana do?

Axana develops and sells Axana MDT, an AI-powered clinical software platform used by NHS and EU hospitals to support multidisciplinary team (MDT) processes in cancer care. The platform automates case preparation, data aggregation, documentation, decision recording, pathway management, and patient follow-up tracking, deployed on-premise or via secure cloud in NHS England-approved data centres.

Is Axana a public or private company?

Axana is a private company. It is classified as unknown and is currently operating.

When was Axana founded?

Axana was founded in 2024. It employs 1 to 10 people.

Where is Axana based?

Axana is headquartered in Amsterdam, Netherlands, in the Europe region.

How does Axana make money?

One revenue line is on record: clinical Software Licensing (Axana MDT).

Who are Axana's main competitors?

Direct peers on record are DrDoctor, Aidence, Concentric Health, Optellum, C the Signs and Kheiron Medical Technologies. Broad incumbents are Brainlab, Babylon Health, Huma (formerly Medopad) and Epic Systems.

Does Axana have an API?

No public API is recorded for Axana.

What industry is Axana in?

Axana's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 541512 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals